GFAP and myeloid sarcoma: Similar results were observed after calculating FLC indexes, with the median λ‐FLC index being 45.5 [28.4; 96.9] in the GFAP astrocytopathy group and 10.6 [2.2; 29.1] in the MS group, respectively, p = 0.002 (Figure 2D).